SlideShare a Scribd company logo
“PHARMWATCH”
MINISTRY OF HEALTH
DRUG MONITORING FORM
Report drug failure and adverse reactions with
medications and suspected counterfeit product
An adverse reaction occurs when the patient outcome is:
Death, life-threatening (real risk of dying), hospitalization (initial or
prolonged), disability (significant, persistent or permanent),
congenital defect, permanent impairment, allergic reactions,
gastrointestinal distress.
Report even if:
 You’re not certain whether the product caused the adverse reaction
 You don’t have all the details
Who can report?
Any health care professional (Physician, Pharmacist, Dentist, Nurse)
Any patient who has experienced an adverse drug reaction
Where to report:
After completing, please return this form to: Dr. Maxine Gossell-Williams
Department of Basic Medical Sciences
Pharmacology Section, University of the West Indies
Tel: 927-2216; fax 977-3823
Email: maxine.gossell@uwimona.edu.jm
or or
Mrs. Valerie Germain Ms. Angelika Steiner
Standards & Regulation Division Standards & Regulation Division
Ministry of Health Ministry of Health
45-47 Barbados Ave, Kingston 5 45-47 Barbados Ave, Kingston 5
Tel: 633-7150: fax: 630-3630 Tel: 633-7148 fax: 630-3630
Email: germainv@moh.gov.jm Email: steinera@moh.gov.jm
For additional information or for reporting online please visit the Ministry of Health’s website at www.moh.gov.jm
“PharmWatch” is a collaborative effort between the Ministry of Health
and
the Pharmacology Section of the University of the West Indies.
What happens when the Form is submitted?
Any information provided in this form will be handled confidentially. The identities of the health care professional, patient or any
other person reporting will be held in strict confidence and protected to the fullest extent. All reports will be assessed and causality
analysis decided by Ministry of Health in due course. It is the ultimate responsibility of MOH to decide how to act on the
information. It is also the responsibility of the Ministry to decide whether the incidences of reports will require further evaluation
of drug performance. The Ministry will further provide the relevant pharmaceutical company with a summary of its findings and
subsequent decision regarding intervention.
Prepared by: Maxine Gossell-Williams
Department of Basic Medical
Sciences Pharmacology Section
Princess Thomas Osbourne
Standards & Regulation Division
Ministry of Health
2009 May
“PHARMWATCH” DRUG MONITORING FORM
A. PATIENT DETAILS
1.Patient Initials:
(First, Last)
3.Gender:
M F
3. Date of Birth:
(mm/dd/yyyy)
4. Ethnicity 5. Weight:((Kg) 6. Height: (cm)
B. SUSPECTED DRUG EVENT
7. Outcomes attributed to use of drug
(check all that apply):
Failure of therapy Allergy
Disability Life threatening
Hospitalisation
Death______________
mm/dd/yyyy
Other (describe)___________________
8. Describe event or problem 9.Date event
started
(mm/dd/yyyy)
10. Date event
ended
(mm/dd/yyyy)
11. Describe action taken in response (e.g.
drug changed, prolonged-therapy, increased
dose)
12. Describe other relevant history including abnormal laboratory test results, days of
hospitalization.
C. DRUG INFORMATION
13.Name of suspected drug
(give specific name on package)
14. Dose & Route 15. Indication 16. Batch number if
known
17. Name of other drugs taken
(give specific name on package)
18. Dose & Route 19. Indication 20. Batch number if
known
D. REPORTING HEALTH PROFESSIONAL INFORMATION
21. Profession:__________________________________
22. Name: _________________________________________
23. Address: _________________________________________________
24.Telephone: _____________
25. Fax: ___________________
26. Email______________________________________
27. Also reported to:
Signature Date (mm/dd/yyyy)
FOR OFFICIAL USE ONLY
Received by:
Date received:
Action taken:
Code No

More Related Content

What's hot

Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
siddhant thakur
 
Vital Signs Edition #1
Vital Signs   Edition #1Vital Signs   Edition #1
Vital Signs Edition #1
ScottJordan
 
Chantix Writing Sample
Chantix Writing SampleChantix Writing Sample
Chantix Writing Sample
Brigitte U. Barrera
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine
Michel Dumontier
 
Top Trends in Orphan Drugs
Top Trends in Orphan DrugsTop Trends in Orphan Drugs
Top Trends in Orphan Drugs
Bill Smith
 
Poster 1 presented at QCOR Baltimore 2014 MLobo
Poster 1 presented at QCOR Baltimore 2014 MLoboPoster 1 presented at QCOR Baltimore 2014 MLobo
Poster 1 presented at QCOR Baltimore 2014 MLobo
LBNicolau
 

What's hot (6)

Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
 
Vital Signs Edition #1
Vital Signs   Edition #1Vital Signs   Edition #1
Vital Signs Edition #1
 
Chantix Writing Sample
Chantix Writing SampleChantix Writing Sample
Chantix Writing Sample
 
20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine20091109 Biol1010 Personalized Medicine
20091109 Biol1010 Personalized Medicine
 
Top Trends in Orphan Drugs
Top Trends in Orphan DrugsTop Trends in Orphan Drugs
Top Trends in Orphan Drugs
 
Poster 1 presented at QCOR Baltimore 2014 MLobo
Poster 1 presented at QCOR Baltimore 2014 MLoboPoster 1 presented at QCOR Baltimore 2014 MLobo
Poster 1 presented at QCOR Baltimore 2014 MLobo
 

Similar to Report drug failure and adverse reactions with medications and suspected counterfeit product. Jamaica

Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Dr Sukanta sen
 
Vigilance
VigilanceVigilance
Vigilance
Alisha Bansal
 
lecture1_2008_p734
lecture1_2008_p734lecture1_2008_p734
lecture1_2008_p734
Flavio Guzmán
 
Health Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand PirouziHealth Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand Pirouzi
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
How to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical PharmacyHow to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical Pharmacy
Drpradeepthi
 
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug MonitoringPHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
Venugopal N
 
Basics Of Pharmacovigilance
Basics Of PharmacovigilanceBasics Of Pharmacovigilance
Basics Of Pharmacovigilance
Naganand Jayakumarswamy
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
Dr. Vijesha Soni
 
importance of pharmcovigilance
importance of pharmcovigilanceimportance of pharmcovigilance
importance of pharmcovigilance
siddemsetty nikhil
 
Pharmacovigilance in Focus by Dr.Prashant, Cipla
Pharmacovigilance in Focus by Dr.Prashant, CiplaPharmacovigilance in Focus by Dr.Prashant, Cipla
Pharmacovigilance in Focus by Dr.Prashant, Cipla
Until ROI
 
Pharmacovigilance System
Pharmacovigilance SystemPharmacovigilance System
Pharmacovigilance System
Alaa Fadhel Hassan Alwazni
 
Pharmacovigilance - an overview
Pharmacovigilance - an overview Pharmacovigilance - an overview
Pharmacovigilance - an overview
S S Shiva
 
Adverse Drug Reaction
Adverse Drug ReactionAdverse Drug Reaction
Adverse Drug Reaction
Nishu Vora
 
Adverse Drug Reaction
Adverse Drug ReactionAdverse Drug Reaction
Adverse Drug Reaction
Nishu Vora
 
Adverse Drug Reaction
Adverse Drug ReactionAdverse Drug Reaction
Adverse Drug Reaction
Nishu Vora
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Fariha Shikoh
 
Metformin paper in egj
Metformin paper in egjMetformin paper in egj
Metformin paper in egj
limgengyan
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Hesham Al-Khateeb
 
Fda med watch
Fda med watchFda med watch
Fda med watch
Sridhar S
 
Pharmacy news 2014
Pharmacy news 2014Pharmacy news 2014
Pharmacy news 2014
munaoqal
 

Similar to Report drug failure and adverse reactions with medications and suspected counterfeit product. Jamaica (20)

Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Vigilance
VigilanceVigilance
Vigilance
 
lecture1_2008_p734
lecture1_2008_p734lecture1_2008_p734
lecture1_2008_p734
 
Health Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand PirouziHealth Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand Pirouzi
 
How to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical PharmacyHow to recognize ADRs in patients.@ Clinical Pharmacy
How to recognize ADRs in patients.@ Clinical Pharmacy
 
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug MonitoringPHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
PHARMACOVIGILANCE - A Worldwide masterkey for Drug Monitoring
 
Basics Of Pharmacovigilance
Basics Of PharmacovigilanceBasics Of Pharmacovigilance
Basics Of Pharmacovigilance
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
 
importance of pharmcovigilance
importance of pharmcovigilanceimportance of pharmcovigilance
importance of pharmcovigilance
 
Pharmacovigilance in Focus by Dr.Prashant, Cipla
Pharmacovigilance in Focus by Dr.Prashant, CiplaPharmacovigilance in Focus by Dr.Prashant, Cipla
Pharmacovigilance in Focus by Dr.Prashant, Cipla
 
Pharmacovigilance System
Pharmacovigilance SystemPharmacovigilance System
Pharmacovigilance System
 
Pharmacovigilance - an overview
Pharmacovigilance - an overview Pharmacovigilance - an overview
Pharmacovigilance - an overview
 
Adverse Drug Reaction
Adverse Drug ReactionAdverse Drug Reaction
Adverse Drug Reaction
 
Adverse Drug Reaction
Adverse Drug ReactionAdverse Drug Reaction
Adverse Drug Reaction
 
Adverse Drug Reaction
Adverse Drug ReactionAdverse Drug Reaction
Adverse Drug Reaction
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Metformin paper in egj
Metformin paper in egjMetformin paper in egj
Metformin paper in egj
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Fda med watch
Fda med watchFda med watch
Fda med watch
 
Pharmacy news 2014
Pharmacy news 2014Pharmacy news 2014
Pharmacy news 2014
 

Recently uploaded

Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 

Recently uploaded (20)

Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 

Report drug failure and adverse reactions with medications and suspected counterfeit product. Jamaica

  • 1. “PHARMWATCH” MINISTRY OF HEALTH DRUG MONITORING FORM Report drug failure and adverse reactions with medications and suspected counterfeit product An adverse reaction occurs when the patient outcome is: Death, life-threatening (real risk of dying), hospitalization (initial or prolonged), disability (significant, persistent or permanent), congenital defect, permanent impairment, allergic reactions, gastrointestinal distress. Report even if:  You’re not certain whether the product caused the adverse reaction  You don’t have all the details Who can report? Any health care professional (Physician, Pharmacist, Dentist, Nurse) Any patient who has experienced an adverse drug reaction Where to report: After completing, please return this form to: Dr. Maxine Gossell-Williams Department of Basic Medical Sciences Pharmacology Section, University of the West Indies Tel: 927-2216; fax 977-3823 Email: maxine.gossell@uwimona.edu.jm or or Mrs. Valerie Germain Ms. Angelika Steiner Standards & Regulation Division Standards & Regulation Division Ministry of Health Ministry of Health 45-47 Barbados Ave, Kingston 5 45-47 Barbados Ave, Kingston 5 Tel: 633-7150: fax: 630-3630 Tel: 633-7148 fax: 630-3630 Email: germainv@moh.gov.jm Email: steinera@moh.gov.jm For additional information or for reporting online please visit the Ministry of Health’s website at www.moh.gov.jm “PharmWatch” is a collaborative effort between the Ministry of Health and the Pharmacology Section of the University of the West Indies. What happens when the Form is submitted? Any information provided in this form will be handled confidentially. The identities of the health care professional, patient or any other person reporting will be held in strict confidence and protected to the fullest extent. All reports will be assessed and causality analysis decided by Ministry of Health in due course. It is the ultimate responsibility of MOH to decide how to act on the information. It is also the responsibility of the Ministry to decide whether the incidences of reports will require further evaluation of drug performance. The Ministry will further provide the relevant pharmaceutical company with a summary of its findings and subsequent decision regarding intervention. Prepared by: Maxine Gossell-Williams Department of Basic Medical Sciences Pharmacology Section Princess Thomas Osbourne Standards & Regulation Division Ministry of Health 2009 May
  • 2. “PHARMWATCH” DRUG MONITORING FORM A. PATIENT DETAILS 1.Patient Initials: (First, Last) 3.Gender: M F 3. Date of Birth: (mm/dd/yyyy) 4. Ethnicity 5. Weight:((Kg) 6. Height: (cm) B. SUSPECTED DRUG EVENT 7. Outcomes attributed to use of drug (check all that apply): Failure of therapy Allergy Disability Life threatening Hospitalisation Death______________ mm/dd/yyyy Other (describe)___________________ 8. Describe event or problem 9.Date event started (mm/dd/yyyy) 10. Date event ended (mm/dd/yyyy) 11. Describe action taken in response (e.g. drug changed, prolonged-therapy, increased dose) 12. Describe other relevant history including abnormal laboratory test results, days of hospitalization. C. DRUG INFORMATION 13.Name of suspected drug (give specific name on package) 14. Dose & Route 15. Indication 16. Batch number if known 17. Name of other drugs taken (give specific name on package) 18. Dose & Route 19. Indication 20. Batch number if known D. REPORTING HEALTH PROFESSIONAL INFORMATION 21. Profession:__________________________________ 22. Name: _________________________________________ 23. Address: _________________________________________________ 24.Telephone: _____________ 25. Fax: ___________________ 26. Email______________________________________ 27. Also reported to: Signature Date (mm/dd/yyyy) FOR OFFICIAL USE ONLY Received by: Date received: Action taken: Code No